Windlas Biotech Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 05/11/2026 ,inter alia, to consider and approve the un-audited standalone financial results for the quarter and half year ended September 30, 2026.

Windlas Biotech Limited Reg. Off.: 40/1, Mohabewala Industrial Area Dehradun, Uttarakhand 248 110, India Tel.:+91-135-6608000-30, Fax:+91-135-6608199 Corp. Off.: 705-706, Vatika Professional Point, Sector-66, Golf Course Ext. Road, Gurgaon, Haryana 122 001, India Tel.:+91-124-2821030 CIN-L74899UR2001PLC033407 October 30, 2026 To To Listing / Compliance Department Listing / Compliance Department BSE Limited National Stock Exchange of India Limited Phiroze Jeejeebhoy Towers Exchange Plaza, C-1, Block G Dalal Street, Mumbai – 400 001 Bandra Kurla Complex Bandra (E), Mumbai – 400 051 BSE CODE: 543329 NSE SYMBOL: WINDLAS Dear Sir/ Madam, Subject: Notice of the Board Meeting scheduled to be held on Thursday, November 5, 2026 Notice is hereby given that pursuant to Regulation 29 of Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, a meeting of the Board of Directors of the Company is scheduled to be held on Thursday, November 5, 2026, inter alia, to consider and approve the un-audited standalone financial results for the quarter and half year ended September 30, 2026. Please be also advised that in accordance with the code of conduct to regulate, monitor and report trading by Designated Persons of the Company pursuant to the SEBI (Prohibition of Insider Trading) Regulations 2015, the Trading Window of the Company is already closed from October 1, 2026, vide our letter dated September 25, 2026, and it shall reopen after the expiry of 48 hours from the date of declaration of the said financial results. This is for your kind information and record. Thanking you, Yours faithfully, For Windlas Biotech Limited Ananta Narayan Panda Company Secretary & Compliance Officer www.windlas.com